Serato, Rose Ann .

HRN: 27-09-34  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/19/2025
CEFUROXIME 500MG (TAB)
06/19/2025
06/25/2025
ORAL
500mg
BID
NSVD With RMLE
Checking Initial Appropriateness 

 Indication:  Prophylaxis    Type of Infection:  Reproductive Tract    Compliance to guidelines: Compliant To Guidelines